SCHEMBL10588483

SCHEMBL10588483

CC(C)CCC[C@@H](C)[C@H]1C[C@@H]2O[C@@]23C2=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]13C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 4/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ ALDH1A1 P00352 1/20 0.62
▸ MAPT P10636 1/20 0.62
▸ ALOX15 P16050 1/20 0.62
▸ HMGCR P04035 2/20 0.48
▸ DHCR24 Q15392 1/20 0.46
▸ CXCR1 P25024 1/20 0.44
▸ PLA2G1B P04054 1/20 0.43
▸ NPC1L1 Q9UHC9 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ CYP8B1 Q9UNU6 1/20 0.41
▸ RORC P51449 3/20 0.41
▸ ABCB1 P08183 1/20 0.41
▸ OSBP P22059 1/20 0.41
▸ OSBP2 Q969R2 1/20 0.41
▸ CYP46A1 Q9Y6A2 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10588487 1.00 USP2 (0.62) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL9766731 0.85 USP2 (0.58) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL9464748 0.84 USP2 (0.65) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL11490959 0.84 USP2 (0.65) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL9464083 0.84 USP2 (0.65) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL9353906 0.83 MEN1 (0.43) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL8430174 0.83 USP2 (0.66) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL11412303 0.83 USP2 (0.63) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL11412547 0.83 USP2 (0.63) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL9769632 0.83 USP2 (0.63) USP2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335106-A2 Novel intermediates and an improved process for producing the compound (3 beta, 5 alpha)-3-hydroxycholest-8(14)-en-15-one AMERICAN CYANAMID COMPANY (US) 1989-10-04 — — EP claimed
Send feedback